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This paper gives a critical review of current problems related to quantitative health risk assessment
of exposure to asbestos, and particularly to chrysotile, the only type of asbestos still available on
the market. The paper reviews types, sources, uses and the main recognised health effects of
asbestos, paying particular attention to the health-related properties of fibres and the role of their
biopersistence. The main focus is on yet unresolved issues which introduce a large margin of
uncertainty into the published quantitative risk assessments: 1) Are all asbestos types equally
dangerous or is chrysotile asbestos less dangerous than amphiboles? 2) Are health effects of
asbestos fibres threshold or non-threshold effects? 3) Are errors in mathematical modelling of
risks so great as to make the risk evaluations worthless? Attention is also given to errors in
estimates of past exposures, uncertainties and unspecificities of models and to the unfeasibility of
practical application of some well recognized risk assessment models.
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In 1989, the US Environmental Protection
Agency (EPA) issued the “Asbestos Ban and
Phase-out Rule”, which would have banned
practically all uses of asbestos in the USA by 1996
(1). In 1991, however, a US Court of Appeals
revoked the ruling. In 1991, the Commission of
the European Communities enacted a Directive
prohibiting the marketing and use of all amphibole
fibres and the products containing them (2). It
also prohibited the use of 14 categories of
chrysotile products, permitting the continuation
of use of the important chrysotile products -
asbestos cement and friction materials. However,
in 1999, the Commission enacted a Directive
prohibiting the use of all asbestos types in EU
member-states by the year 2005 (3). Thus in the
two parts of the Western world developed an
unusual situation of conflicting regulatory
approach to the use of asbestos, an issue loaded
with scientific controversies for years. The
problem induces a dilemma for the responsible
authorities in Croatia: Should the country follow
the ‘ban approach’ of the EU or the ‘controlled
use’ approach of the International Labour
Organization (ILO) (4), the latter practically
supported by the current regulatory situation in
the US (official exposure limits)? If the former
approach is selected, which is likely in view of
the political interest of the country to join the EU,
should the rule be applied by the year 2005,
although Croatia will not yet have become the
member of EU at the time?
TYPES OF ASBESTOS, THEIR SOURCES
AND USE
My recent article “Asbestos and Health”
describes the types, sources and the use of
asbestos in detail (5). There are two basic
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Table 1 Main asbestos-containing products
Product Uses
Asbestos-cement products Water supply and sewage piping
Drain pipes and guttering
Interior wall panels
Casings for electrical wires
Fire protection material
Chemical tanks
Asbestos friction products Clutch facings
Brake lining for road and railway vehicles
Industrial friction materials
Asbestos paper products Table pads and heat-protective mats
Heat and electrical wire insulation
Industrial filters for beverages
Underlining material for sheet flooring
Asbestos textile Packing components
Heat and fire-resistant clothing
Fire-proof curtains
Asbestos felt products Noise insulation
other asbestos products Ceiling tiles
Gaskets and packing
Paints, coatings and sealants
Patching tape
Plastics
mineralogical groups of asbestos: serpentine and
amphibole. Chrysotile (white asbestos) is now the
only commercially important member of the first
group which accounts for more than 98% of the
current world consumption of asbestos. The main
members of the amphibole group of minerals are
amosite (brown asbestos), crocidolite (blue
asbestos), and tremolite which mainly occurs as
an impurity of chrysotile. Only the first three
asbestos types have found commercial use. In
general, asbestos minerals are characterised by
high tensile strength, flexibility and durability, as
well as heat insulation and flame retardant
properties. In addition, they do not evaporate,
burn or undergo significant reactions with
chemicals. Asbestos has been used in thousands
of products (see Table 1 for the brief list).
Currently, asbestos is used principally in high-
density products in which the asbestos fibres are
embedded in a cementitious or resinous matrix.
Asbestos-cement products, mostly pipes (for
drinking water supply, sewage disposal and
irrigation), shingles and sheets, account for about
85% of the total use of asbestos.
Natural erosion and many human activities are
the sources of asbestos fibres. The latter range
from ore recovery and processing, manufacturing,
application and usage, to disposal activities.
Fibres are also released during the construction
and demolition of buildings and possibly during
maintenance. Asbestos was produced in 24
countries in the world. In addition, the
manufacture of asbestos-containing products
took place in more than 100 countries. The world
production peaked at over 5 million tonnes, but
has been declining since the mid-1970’s. The
current production is about 2 million tonnes (6).
HEALTH EFFECTS
There is no consistent evidence that drinking
or eating asbestos is associated with adverse
health effects (7-11); only exposure to airborne
asbestos fibres is a proven cause of disease. All
types of asbestos, if inhaled at sufficient doses,
can cause three main serious health disorders:
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asbestosis, lung cancer, and mesothelioma.
Significant overt clinical symptoms of asbestosis
are unlikely to appear until approximately 20
years after the onset of exposure. No asbestosis
has been found in the general population, except
in populations living in the immediate vicinity of
intense and uncontrolled sources of emission. It
usually takes 20-40 years between the first
exposure to asbestos fibres and the onset of lung
cancer. Smokers are at a considerably greater
risk of developing lung cancer than nonsmokers.
Mesothelioma takes between 30 and 50 years to
develop. This form of cancer is unavoidably fatal.
Increased mortality rates have been observed in
non-occupationally exposed subjects sharing the
household with asbestos workers, or living in the
vicinity of uncontrolled asbestos emission
sources. It remains to be seen whether the
observed and projected increases of
mesothelioma mortality in the general population
of the USA, New Zealand, and some European
countries (12-19) are the effects of exposure to
asbestos, and particularly to chrysotile, or not.
Unlike in cancer, smoking does not contribute to
the development of mesothelioma.
HEALTH-RELATED PROPERTIES OF
FIBRES
Negative health effects are induced only by
fibres which are inhaled, deposited and retained
in the respiratory tract. Only fibres thinner than 3
µm, having an aerodynamic diameter of about
10 µm, can enter the conducting airways of the
respiratory tract. Longer fibres are more
dangerous. Therefore, in the regulations of many
countries, as well as in some international
recommendations (20), asbestos fibres to be
measured in occupational environmental
assessment are defined as those having a
diameter ≤3 µm, length ≥5 µm, and length to
diameter ratio at least 3:1 (“regulated fibres”).
There is evidence that the most hazardous
asbestos fibres are those longer than 5-8 µm and
thinner than 1.5 µm. Early experimental results
of Stanton and Layard (21) and Pott (22)
indicated that implanted asbestos fibres of length
to diameter ratio <5:1 are not carcinogenic, that
the carcinogenicity of fibres of length to diameter
ratio <10:1 is small, and that only fibres of length
to diameter ratio >10:1 have significant
carcinogenic properties. The conclusion is that it
would be justifiable to measure fibres of length to
diameter ratio >10:1 in the environmental health
assessment (23, 24).
Biopersistence is also considered an important
health-related property of asbestos fibres. It
depends on the relative insolubility of the fibre,
that is, on its retention in the respiratory tract. It
is generally believed that the greater the
biopersistence, the higher the probability of
fibrogenic or carcinogenic effect (5, 25), although
there are opinions that long retention of fibres in
the respiratory tract is not the prerequisite for the
formation of neoplasms (26).
UNRESOLVED ISSUES
In spite of years of studies of the effects of
asbestos fibres and hundreds of scientific and
other papers published, there remains a number
of unresolved issues and unanswered questions.
Are all asbestost types equally dangerous?
Scientists and regulators are divided on this
issue in two apparently irreconcilable groups.
Some believe that the risk of exposure to
amphiboles, particularly to crocidolite, is
considerably higher than the risk of exposure to
chrysotile. A minority disagree. In 1977, a group
of experts of the Commission of the European
Communities (CEC) concluded that there was
general agreement that the risk of mesothelioma
was fibre-related and decreased from crocidolite
to amosite to chrysotile (27). The summary of a
consultation of the World Health Organization
(WHO) on occupational exposure limits for
asbestos (28) says the following:
The human evidence suggests a lower risk
of lung cancer from exposure to chrysotile
than to crocidolite or amosite [...] Pleural
mesothelioma has been produced by all
types of asbestos fibre, but in general, the
human evidence suggests a much lower
risk from exposure to chrysotile than to
crocidolite or amosite. Peritoneal
mesothelioma can be produced by
crocidolite and amosite, but has probably
not been produced by chrysotile.
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Source Chrysotile Amosite Crocidolite
WHO (1989) 1 <1 <1
ACGIH (1995/1996) 2 0.5 0.2
EPA (1989) ban ban ban
OSHA (1994) 0.1 0.1 0.1
Croatia (1992/1993)* 2 1 0.5
Chrysotile Other asbestos types











United Kigdom 0.5 0.2
EU 0.6 0.3
*Exposure limits expressed as counts of fibres of undefined dimensions
Table 2 Occupational exposure limits (f/ml) for chrysotile and amphiboles
A Working Group of the International Programme
on Chemical Safety (IPCS) on the Reduction of
Asbestos in the Environment (29) recommended
as follows: “In any given situation, priority should
be given to the control of air pollution by
amphibole asbestos fibres (crocidolite, amosite,
tremolite)”. The 1996 CEC’s evaluation says:
Recent studies have shown that amphibole-
type fibres are more harmful than
chrysotile... In general, epidemiologically,
the risk levels seem to be, in descending
order, crocidolite and amosite (two
amphibole types of asbestos), followed by
chrysotile and anthophyllite (another
amphibole) (30).
The latest evaluation of IPCS/WHO in 1998 (31)
agreed with the previous evaluation of 1986 (7)
that “the risk of mesothelioma in persons exposed
to chrysotile is lower than the risk in persons
exposed to crocidolite or amosite”.
There are scientists and regulators who do not
agree with the significant difference in the potency
between fibres of different asbestos types. This is
reflected in different approaches of the two groups
in setting exposure limits. It is obvious that
exposure limits for amphiboles must be lower than
for chrysotile if the risks of exposure to the former
are higher. Table 2 reflects the differences in the
approach of authorities in a number of member
states of EU (30); while the exposure limits are
higher for chrysotile than for other types of
asbestos in Belgium, France, Greece, Italy,
Netherlands, Spain, United Kingdom and EU,
there is no difference in Austria, Denmark, Finland
or Germany. The prestigious American
Conference of Governmental Industrial Hygienists
(ACGIH) also differently evaluated chrysotile and
amphibole asbestos (32). However, the US
Occupational Safety and Health Administration
(OSHA) (33) does not accept this approach - just
like EPA which attempted to prohibit all the
asbestos types (1). Under the influence of these
US governmental agencies, the ACGIH, in its
latest list of threshold limit values (34), adopted
the OSHA limit of 0.1 f/ml for all asbestos fibres.
It is surprising, however, that they included
chrysotile among substances for which
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Asbestos process or use Types of fibre KLx10
4
Textile production Predominantly 200
Chrysotile
Friction products Chrysotile 2.3
manufacturing
Mining and milling Chrysotile 9.8
Amosite insulation Amosite 430
production
All processes Amosite 65
Chrysotile
Crocidolite
All processes Amosite 100
except mining Chrysotile
and milling Crocidolite
Table 3 Weighted values of unit exposure risk KL (36)
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information is being solicited, which suggests
doubts about the TLV of this substance. Table 2
shows that Croatia has enacted different exposure
limits for different asbestos types (35), but the
fibres are not physically specified.
Table 3 shows the EPA’s inconsistency in the
approach to carcinogenic potency of different
asbestos fibres. It shows modified values of the
coefficient KL, taken from an EPA publication (36),
indicating considerable differences in the potency
of different asbestos fibres. The coefficient KL
reflects the carcinogenic potential of the exposure
to carcinogens; it is the estimated increase in lung
cancer risk due to one-year exposure to the unit
concentration of 1 f/ml. The values presented in
Table 3 clearly show that the carcinogenic risk is
by far the lowest in the exposure to chrysotile
only, with the exception of chrysotile in textile
production. Exposure to amosite fibres alone
involves a much greater risk, as is the case with
the combined exposure to amphiboles and
chrysotile. The high KL value in pure chrysotile
textile production is attributed to a significantly
higher content of more carcinogenic long
chrysotile fibres in the textile production (37-40).
Rich evidence of the significant difference in
the potencies between fibres of chrysotile and
amphiboles gave grounds for introducing “the
chrysotile hypothesis” and “the amphibole
hypothesis”. The first says that the human risk
becomes acceptable at a sufficiently low exposure
level to chrysotile, and the second that the
carcinogenic risk at low concentrations of
chrysotile is present only if amphiboles are also
present. These hypotheses are not generally
accepted; they have particularly been rejected by
the US regulatory agencies (1, 33) and by the
Ramazzini Society (12, 41). The controversy
about whether there is a difference in the
carcinogenic potency between chrysotile and
amphibole fibres is continued in more recent
papers by most reputable authors in the field.
While Berry (42), Landrigan an co-workers (43),
and Dement (44) believe that chrysotile is less
potent than amphiboles in its ability to cause
mesothelioma, and Hodgson and Darnton (45)
conclude that specific risks of mesothelioma from
chrysotile, amosite and crocidolite are in the ratio
1:100:500, respectively, Landrigan and co-
workers and Dement consider that the lung cancer
risk from chrysotile is at least as high as that from
amphiboles, and Smith and Wright (46) regard
chrysotile as the main cause of pleural
mesothelioma in humans. While McDonald and
McDonald (50) and McDonald (53) state that the
carcinogenic risk at present day levels of exposure
to commercial chrysotile is vanishingly small and
that the remaining risk is due to contamination of
chrysotile by the amphibole tremolite, Dement
(44) maintains that chrysotile should not be
controlled differently than other asbestos types.
In the cohort of some 11,000 Quebec miners
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and millers (47-53), 25 cases of mesothelioma
were identified from miners in the Thetford Mines
region and 8 from the large mine at Asbestos.
The proportion of tremolite in the chrysotile was
3 times higher in the former than in the latter
region. The analysis of deaths from mesothelioma
in men employed in the Thetford Mines, with
matched references, showed that odds ratios for
work in the central mines, where the tremolite
content was 3 times higher, were significantly
elevated for mesothelioma and lung cancer. By
contrast, in the peripheral mines, where the
tremolite content was 3 times lower, there was
little or no evidence of increased risk. The authors
conclude that these long-term studies - including
data from as early as 1970’s - show that chrysotile
rarely caused mesothelioma and was not a major
cause of lung cancer, except at very high levels
of exposure. They attribute the remaining risk to
tremolite, because its biopersistence is much
higher than that of chrysotile. However, the Mount
Sinai group (54) in their analysis of the lung and
mesothelial tissues taken from 151 human
malignant mesothelioma cases, found asbestos
fibres in almost all the lung tissues as well as in
the mesothelial tissue, the most common
asbestos types being an admixture of chrysotile
and amphiboles, followed by amphiboles alone
and chrysotile alone. The most common of
asbestos types in the mesothelial tissues were
chrysotile alone, followed by chrysotile plus
amphibole, and amphibole alone. They conclude
that chrysotile can induce human malignant
mesothelioma without the presence of
amphiboles, since, in some of the mesothelioma
cases, the fibres detected in the lung or
mesothelial tissues were exclusively chrysotile
fibres.
The controversy continues.
Are health effects of asbestos fibres threshold or
non-threshold effects?
All asbestos-related diseases are dose-related:
the higher the concentration and duration of
exposure, the higher the prevalence of the disease
and mortality. However, the form of the dose-
response curve at low doses, typical for the
exposure of general population, is not known.
There are contradictory opinions as to whether
the dose-response relationship in the region of
low doses is linear or not. It is practically
impossible to measure the effects at such low
doses either epidemiologically or experimentally.
It is for this reason that mathematical
extrapolations (“low-dose extrapolations”), which
carry errors of several orders of magnitude, are
used in the quantitative risk assessments. I
criticised these extrapolations in 1988 (55) and
again in 1991 (56) and 1993 (57). Recently, in
2001, Berman (58) reported that “the published
dose-response coefficients for asbestos vary by
more than a factor of 500 for lung cancer and
more than a factor of 1,000 for mesothelioma”.
Extrapolation of the most frequently used linear
relationship into the origin of coordinates means
that there is no exposure threshold, i.e. that even
the lowest exposure to asbestos may carry some
risk of disease and death. Others, however,
believe that there is an asbestos fibre exposure
threshold for chrysotile below which there will be
no pathologic effects (particularly asbestosis or
lung carcinoma) or that the effects are so rare
that they can not be epidemiologically detected.
As negative effects can not be proven in practical
risk assessment, the issue remains unresolved.
An expert group of the CEC concluded the
following in 1977 (27):
It is impossible to come to reliable
quantitative assessment of the risk of
malignancies for the general public. It is
possible that there is a level of exposure
(perhaps already achieved in the general
public) where the risk is negligibly small.
The evaluation of IPCS/WHO in 1986 (7) was:
In the general population the risks of
mesothelioma and lung cancer attributable
to asbestos can not be quantified reliably
and are probably undetectably low.
Cigarette smoking is the major etiological
factor in the production of lung cancer in
the general population. The risk of
asbestosis is virtually zero.
However, the latest IPCS/WHO evaluation in
1998 (31) stated that no threshold had been
identified for carcinogenic risks from chrysotile
asbestos. There is an almost general consensus
that no threshold exists for amphiboles. There is
still a controversy as to whether there is a
threshold, or at least a practical threshold, for
chrysotile. Studies are limited to only two
industrial cohorts with relatively pure exposure
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MINERS TEXTILE WORKERS
Exposure Deaths Standard Exposure Deaths Standard
(f/ml x yrs) O/E mortality (f/ml x yrs) O/E mortality
<10 36/31.4 1.14 <1.4 7/7.6 0.92
10<33 28/25.3 1.11 1.4-2.7 4/5.5 0.73
33<99 33/31.3 1.05
99<198 39/24.4 1.60 2.7-6.9 15/6.2 2.4
198<330 26/22.8 1.14 6.9-27.0 10/5.1 1.96
330<660 32/28.3 1.13 27-110 16/5.2 3.08





O - observed; E - expected
Table 4 Lung cancer mortality in relation to cumulative exposure (39,48)
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to chrysotile fibres containing sufficient high
quality data for exposure-response analysis.
These studies include the Quebec miners and
millers (47-53, 59) and South Carolina textile
workers (37-40). Table 4 shows standard
mortality from lung cancer in Quebec miners and
millers (48), 1976-1988, in relation to exposure
accumulated up to the age of 55 years, and the
lung cancer mortality by cumulative exposure in
South Carolina workers (39) employed between
1940 and 1990. There is no indication of a trend
in standard mortality over 7 lowest categories of
exposure of miners and millers (<10-<990 f/ml
yrs). The standard mortality was elevated at the
three highest levels, i.e. at the cumulative
exposure of more than 990 f/ml yrs. A completely
different result was obtained in South Carolina
textile workers. There was a consistent increase
in the risk of lung cancer with increasing
cumulative exposure in all the exposure
categories of cumulative exposure more than 2.7
f/ml yrs. The proportional mortality from
mesothelioma in the Quebec cohort was only
0.45% (33 deaths among 7,312 workers) by the
end of 1988. Comparing the very high slope of
0.021 per f/ml yr  in textile workers with the very
low slope of 0.0005 per f/ml yr in Quebec miners
and millers, the authors of the last exposure
response analysis (40) attribute this large
difference to the considerably higher proportion
of carcinogenic long fibres in the textile
production. It was on the basis of the results
obtained in Quebec workers that the authors (48,
50, 53) concluded that chrysotile was not the
cause of lung cancer, except at very high levels
of exposure above 25-30 f/ml, well above current
exposure even under poor conditions. Can the
finding that there was no trend in standard
mortality over 7 lowest exposure categories of
miners and millers be taken as the basis for the
conclusion that there is a practical threshold for
chrysotile (49)?
The situation with mesothelioma is somewhat
different. The standard mortality rates in several
countries show an increasing trend. The results
of some evaluations caused panic. British (14,
19), French (17), New Zealand (15), and the US
(12, 18) data projected thousands of deaths per
year of mesothelioma in the decades to come.
As a considerable proportion of diagnosed
mesothelioma was believed to be the
consequence of exposure to asbestos fibres, there
is a tendency to attribute all these deaths to the
effects of these fibres without an objective proof
and without differentiating the type of fibres. It is
worth noting that the description of mesothelioma
in literature preceded the exploitation of asbestos
(59) and that other causes of mesothelioma have
also been described (60). The role of Simian virus
SV40 in the development of human mesothelioma
has recently received more attention. Some
authors (60) assume that SV40 may contribute
to the development of human mesotheliomas that
occur in people not exposed to asbestos.
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Table 5 Concentrations in mines and towns of Canada: 1973-1995 (63)
Mines Towns
Year Mean value Highest value Lowest value Mean value
1973 15.9 52.2 4.3 0.08
1974 11.4 24.7 3.3 0.08
1975 8.7 16.7 2.7 -
1977 2.6 5.4 1.5 0.04
1979 1.1 2.0 0.7 0.05
1981 1.0 1.5 0.6 0.02
1983 0.8 1.0 0.5 <0.01
1985 0.7 1.4 0.3 <0.01
1987 0.5 0.9 0.1 <0.01
1989 0.7 0.9 0.5 <0.01
1991 0.6 0.7 0.3 <0.01
1993 0.4 0.5 0.3 <0.01
1995 (0.4) (0.5) (0.2) <0.01
Results in parentheses - personal communication
However, they state that the available
epidemiologic data are insufficient to explain the
role that SV40 may have played in contributing
to the increased incidence of mesothelioma
currently recorded. Other authors (18, 61, 62)
propose that asbestos and SV40 may be
cocarcinogens.
The latency period for the development of
mesothelioma is between 30 and 50 years, so
that the current mesothelioma deaths are
predominantly the consequence of exposure to
mixtures of chrysotile and amphiboles in the far
past when the exposure levels were incomparably
higher than those of today. It is impossible to
evaluate whether the current (considerably lower)
exposures to pure chrysotile would bring about
similar consequences.
UNCERTANTIES IN RISK ASSESSMENT
Errors in estimates of past asbestos exposure
The current mortality from asbestos-related
cancer is the consequence of exposures of 20-
50 years ago, or even longer. There is no doubt
that the exposure levels in the distant past were
considerably higher than those of today. As an
example, Table 5 shows the concentrations
measured in mines and towns of Canada in the
period 1973 to 1995 (63).
In the distant past, the techniques of exposure
measurement did not specify asbestos fibres, but
referred to either gravimetric concentration of total
particles in the air, expressed in grams or mg per
m3 or, later, to count concentrations of particles
(not fibres) expressed in million particles per cubic
foot of air (mppcf). Thus, the early methods
measured all particles, of which fibres constituted
only a minor fraction. As exposure levels in the
past must be taken into account in the quantitative
risk assessment, various authors estimated
assumed specific concentrations of airborne
asbestos fibres converting the measured
gravimetric or count concentrations of total
particles to the currently defined fibres using a
number of mathematical conversions. These
conversions relied on many dubious assumptions
and approximations, and included errors of
several orders of magnitude into the mathematical
estimates of historical airborne fibre
concentrations. This is one of the main reasons
why I cautioned - quite early - that the quantitative
risk assessment equations and particularly low
dose extrapolations used for predicting mortality
or morbidity in populations exposed to
considerably lower exposure levels were very
uncertain (56,57). Table 6 shows some errors in
the conversion of such concentrations. The first
part of the table shows the relationships between
asbestos fibre diameter and length and the
concentration expressed in fibres per ml for the
gravimetric concentration of 10 ng/ml air [based
on calculations by Pott (22)]. The table shows
that the same air with weight concentration of 10
ng/ml may contain 32 f/ml if the fibre diameter
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Table 6 Variations in concentration conversions
Table 7 Lifetime risk estimates of mesothelioma death in seven studies (65) based on equation L = c (0.0004) (73)k
c k 2.6 3.0 3.2 3.5 3.8 4.0 5.0
0.85x10-8 0.2 1.3 3.0 11 41 97 7000
2.53x10-8 0.7 4 9 34 120 290 21000
7.22x10-8 2 11 26 96 350 820 60000
(exposure level 0.0004 f/ml, lifetime 73 years)
Table 8 Cancer cases predicted by EPA to be avoided by the ban of asbestos use in the future period of 13-15 years (56)
Product 1986 (36) 1988 (66) 1989 (1)
Vinyl-asbestos floor tiles 468 0.0 -
Friction products 386 282.0 99.39-143.7
Asbestos-cement pipes 82 6.0 2.10-4.38
Asbestos-cement plates 31 0.9 0.70-1.51
Gaskets - 14.0 6.68-42.54
Others 33 12.9 39.13-9.87
Total 1,000 315.8 148-202
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is 2.0 µm and the length 40 µm, while it may
contain 8,200,000 f/ml of fibres with the diameter
0.03 µm and the length 0.63 µm. The errors
involved in the conversion of weight
concentrations of total particles of unknown size
distribution into the count concentrations of fibres
of a defined size fraction are so great that the
obtained results may be complete nonsense.
Table 6 also shows an example of EPA’s
conversion in 1986 (36). EPA took 30 (the
geometric mean of conversion factors ranging 0.5-
150 obtained in six studies) as the conversion
factor to be used, introducing a possible error of
more than 200 in the conversion. Robock reported
in 1984 (64) that the conversion factor for
converting mppcf into f/ml obtained in a large
number of samples was between 0.5 and 47.8,
which introduces a hundredfold error into
conversions.
Uncertainties and unspecificities of models
Table 7 shows the estimation of lifetime risk
due to lethality from mesothelioma (L: excess
deaths per million population) induced by the
asbestos concentration of 0.0004 f/ml for an age
of 73 years, calculated by the well known equation
of the National Research Council of the US
National Academy of Sciences (NRC/NAS)
L = C (conc.) (age)K (65). Using the values of the
coefficients C (0.85-7.22x10-8) and K (2.6-5.0),
obtained in epidemiological investigations, the
number of calculated excess deaths ranges from
0.2-60,000 per million population, yielding a ratio
of up to 300,000 in estimated mortality per million
population and rendering the risk assessment
meaningless (56).
In 1991, I criticised (56) those EPA’s
uncertainties in risk assessments which led to their
proposal of the asbestos ban. Table 8 shows the
number of cancer cases expected by EPA to be
No. of asbestos fibres in ml of air
corresponding to weight concentration of 10 ng/
ml (22)





Conversion of weight concentration to no.of
fibres per unit volume (36)
µg/m3➝f/ml 0.5-150 (from 6 studies)
30 (geometric mean)
Conversion of particles per unit volume into
no. of fibres per unit volume (64)
mppcf➝f/ml 0.5-47.4
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avoided in 13 years following the proposed
asbestos ban, as set forth by three consecutive
EPA proposals. The very fact that the number of
cancers varied from 1,000 in 1986 (36) to 315.8
in 1988 (66), ending with 148-202 in the Final
Rule of 1989 (1), sheds strong doubt on EPA’s
risk estimates.
I wish to single out the problem of asbestos-
induced cancers due to exposure to friction
materials. In the Final Rule of 1989 (1), EPA
attributes up to 144 projected cases of cancer to
the exposure to friction materials. These risks
account for the majority of all the risks in the Final
Rule. These risk assessments were obtained using
exposure-response relationships for cancer in
different industries and in populations exposed
to different asbestos materials of which the friction
material is only one. In their study of more than
13,500 workers manufacturing friction materials
in the period 1942-1980, Berry and Newhouse
(67) found little excess cancer, and the only
excess mortality comprised 10 deaths from
pleural mesothelioma, out of which 8 at least
partly due to exposure to crocidolite. The slope
for increased lung cancer risk was only 0.00058
fibres/ml years. McDonald and co-workers (68)
found practically no lung cancer risk and no
mesothelioma in the group of long-term workers
and in higher exposure categories in their study
of more than 3,500 men employed in the
manufacturing of friction products in the period
1938-1958. The slope for increased lung cancer
risk was practically zero. The authors interpreted
the results as “doubtful whether there was any
significant lung cancer excess”. I strongly
disagreed (57) with the approach to the
estimation of the projected number of cancers
using the mean of slopes derived in all studies, of
which only two (by far the lowest) were obtained
in the friction products exposures. The population
with expected exposure to asbestos fibres are
garage mechanics, because of their work on the
maintenance and repair of automobile asbestos-
containing brakes and clutches. In a large case-
control survey of all cases of mesothelioma
diagnosed by pathologists in the USA and Canada
during a defined period, McDonald (69) observed
a substantial excess risk of mesothelioma in many
occupations with exposure to asbestos, and
particularly to amphiboles, but no excess was
observed in the category of garage mechanics.
In 1988 (70) I analysed all the available literature
regarding asbestos risk in vehicle manufacture,
maintenance and repair, and concluded that,
provided good work practices are followed and
no amphiboles are used, detectable risks in
vehicle maintenance and repair are not to be
expected. As in 1991 (56) and 1993 (57), I still
disagree with the EPA’s approach to the
estimation of the projected number of cancers
due to exposure to friction materials by using a
mean slope of 11 studies (1, 36), of which only
two (having by far the lowest slopes) were
obtained in the friction products exposure. It is
hardly justifiable to estimate risks due to exposure
to one type of fibre population by using the slopes
obtained in exposure to completely different fibre
populations, while being fully aware of the large
variations among the slopes. This approach has
resulted in an ungrounded overestimation of the
projected number of cancers in exposure to
friction materials.
Unfeasibility of practical application of risk
assessments
As early as in 1988 and later in 1993, I pointed
to the implications and practical unacceptability
of the results of some well-known published
asbestos risk estimates (55, 57). Table 9 shows
my calculations of exposure limits for asbestos
in the atmosphere derived from some of these
risk assessments.
A 1986 WHO Expert Meeting proposed the
lifetime risk estimate for smokers (mesothelioma:
12x10-5, lung cancer: 16x10-5 as upper limits of
the number of expected deaths per 100,000
population) at an assumed airborne asbestos fibre
concentration of 500 f/m3 (71). Assuming that
the acceptable risk, used for carcinogens in the
WHO Water Quality Guidelines (72), is 1x10-5,
the calculated exposure limit is 18 fibres per cubic
meter of air. Taking the risk estimate of 13.5x10-5
for nonsmokers and using the same acceptable
risk (1x10-5), the obtained exposure limit is 37
fibres per cubic meter. Confronted with prevalent
concentrations found in the air of rural areas with
no specific asbestos sources (up to 100 f/m3) (7),
these exposure limits seem to suggest that in
areas without any specific source of asbestos
emission, a nearly 6-fold reduction of current
asbestos levels would be required, which is
practically impossible to achieve.
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Table 9 also illustrates that an exposure limit of
45 asbestos fibres per cubic meter can be derived
from the asbestos risk estimate published in the
WHO Air Quality Guidelines in 1987 (11x10-5 for
a population with the hypothetical proportion of
30% smokers) (73). This value is lower or as low
as the concentrations found in rural areas without
specific asbestos emission. The table also shows
prevalent asbestos fibre concentrations in urban
areas (from fewer than 100 to 10,000 per cubic
meter) (7).
Table 10 shows the same calculations on the
basis of the risk assessment by the NRC/NAS
(65). Applying the same level of acceptable risk
(1x10-5) and using the number of estimated
deaths from mesothelioma and lung cancer for
male smokers and nonsmokers at the assumed
asbestos concentration of 400 fibres per cubic
meter, the respective calculated exposure limits
are 9 and 22 fibres per cubic meter. In other
Table 9 Estimated lifetime risks from exposure to asbestos at 500 f/m3 and calculated threshold limit values at the assumed acceptable risk
of 1x10-5 (57)
Expert meeting (71) Risk (smokers):
(upper limit) 12x10-5 (mesothelioma) + 16x10-5 (lung cancer) = 28x10-5
TLV on the basis of accceptable risk 1x10-5: 500/28 ~ 18 f/m3
Risk (non-smokers):
12x10-5 (mesothelioma) + 1.5x10-5 (lung cancer) = 13.5x10-5
TLV on the basis of accceptable risk 1x10-5: 500/13.5 ~ 37 f/m3
Air Quality Risk (30% smokers):
Guidelines (73) 1x10-4 (mesothelioma) + 1x10-5 (lung cancer) = 11x10-5
TLV on the basis of accceptable risk 1x10-5: 500/11 ~ 45 f/m3
Prevalent asbestos concentrations: rural areas<100 f/m3, urban areas<100-10000 f/m3,indoor
400-500 f/m3
Mesothelioma 15.6x10-5
Lung cancer — male smoker 29.2x10-5
Lung cancer — male non-smoker 2.7x10-5
Lung cancer — female smoker 10.5x10-5
Lung cancer — female non-smoker 1.4x10-5
Risk — male smokers: 15.6x10-5 + 29.2x10-5=44.8x10-5
TLV on the basis of accceptable risk 1x10-5: 400/44.8 ~ 9 f/m3
Risk — male non-smokers: 15.6x10-5 + 2.7x10-5=18.3x10-5
TLV on the basis of accceptable risk 1x10-5: 400/18.3 ~ 22 f/m3
*National Research Council of the US Academy of Science, 1984 (65)
Table 10 Estimated lifetime risks* from exposure to asbestos at 400 f/m3 and calculated threshold limit values at the assumed acceptable
risk of 1x10-5 (57)
words, these limits require a nearly 10-fold
reduction of asbestos fibre levels in rural areas
without specific asbestos emission!
It is obvious that mathematical extrapolations
of asbestos risk lead to unfeasible threshold limit
values.
CONCLUSIONS
There is no doubt that fibres of all the prevalent
forms of asbestos can cause lung cancer and
mesothelioma. The weight of evidence
convincingly suggests that amphiboles are more
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potent carcinogens than chrysotile. No threshold
has been identified for any of the types of asbestos
except possibly for chrysotile; a practical
threshold was found in chrysotile mining
operations, in the manufacturing of chrysotile
friction products and in some cohorts of workers
in asbestos-cement production. The unit risks,
estimated in studies acceptable as regards the
number of examinees, the duration of follow-up
and the quality of data vary by several orders of
magnitude. To a large extent, this is the
consequence of considerable uncertainty in the
estimates of past exposure levels due to errors in
conversion from weight (µg/m3) or count (mppcf)
concentrations of total particles to the currently
used count concentrations of defined fibres. The
practical application of unit risks of such
uncertainty leads to unachievable exposure limits.
In spite of hundreds of papers published on
asbestos health effects, there are still important
unresolved issues. The effects seen today are the
consequence of uncertain exposure of 20-50
years ago. It cannot be predicted with any degree
of certainty what will the consequences of the
current, incomparably lower exposure levels be
in the future. Yet, there is no doubt that it is
advisable to replace any potential carcinogen with
noncarcinogenic or less carcinogenic material
whenever possible. At this point in time, however,
there are few materials of known toxicity/
carcinogenicity and at least equal technological
performance. There is a potential for the
development of such materials, but their
toxicological properties have not been evaluated
sufficiently. This is the main problem the world is
facing on the eve of the possible worldwide
asbestos ban, which will be considered in the
second part of this paper: “The Asbestos
Dilemma: II. The Ban”.
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Saæetak
DILEMA O AZBESTU I OCJENA RIZIKA
KritiËki su prikazani danaπnji problemi u vezi s kvantitativnom ocjenom zdravstvenih rizika
izloæenosti azbestnim vlaknima, a posebno vlaknima krizotila, jedinog preostalog tipa azbesta u
komercijalnoj uporabi. Dan je pregled izvora, tipova i uporabe, uloge bioperzistencije vlakana te
odnosa njihove duljine i promjera vaænih pri ocjeni rizika. Glavna je pozornost dana nekim joπ
nerazrijeπenim pitanjima koja uvode velike granice nepouzdanosti u objavljene kvantitativne ocjene
rizika: 1. Jesu li svi tipovi azbesta jednako opasni ili se prihvaÊa pretpostavka da je krizotil manje
opasan? 2. Jesu li zdravstveni uËinci izloæenosti azbestnim vlaknima uËinci s pragom izloæenosti
ili bez praga? 3. Jesu li pogrjeπke u matematiËkome modeliranju rizika tako velike da ocjenjivanje
postaje bezvrijedno? S time su u vezi analizirane pogrjeπke ocjenjivanja razina izloæenosti u proπlosti
te nesigurnosti i nespecifiËnosti objavljenih matematiËkih modela kvantitativnog ocjenjivanja rizika.
Primjerima je upozoreno na nemoguÊnosti praktiËke primjene nekih priznatih modela ocjenjivanja.
KLJU»NE RIJE»I: amfiboli, bioperzistencija, krizotil, ocjenjivanje rizika, prag rizika
